Aquilant, part of Healthcare 21 UK, is pleased to announce a new distribution partnership with DK MedTech, bringing its peripheral scoring balloon range to clinicians across the UK. The agreement strengthens Aquilant’s peripheral arterial disease (PAD) portfolio and reflects our wider commitment to delivering best-in-class technologies to the NHS.
DK MedTech’s peripheral scoring balloons expand access to advanced plaque modification tools, giving vascular teams greater choice when managing complex cases and helping to drive better outcomes for patients.
Working hand in hand with DK MedTech and vascular teams nationwide, Aquilant will continue to grow its presence in the peripheral space, ensuring clinicians have access to reliable, evidence-based solutions that meet the demands of an increasingly complex caseload.
United Kingdom
Ireland